ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Clinical Trial of the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic Children (VPH)

This study has been completed.

Sponsored by: Vachira Phuket Hospital
Information provided by: Vachira Phuket Hospital
ClinicalTrials.gov Identifier: NCT00670891
  Purpose

Autism is a developmental and behavioral pattern which includes the triad of impairments, 1. social interaction 2. social communication 3. imagination. Inevitable difficulties in the treatment, managing and handle with autistic children are the main problems. Their memories are seemingly in picture or photo records, which are difference from normal population. There are many concepts but no concise in causative factors, including useful treatments, useless and prolong remaining in many studies.

HBOT (Hyperbaric Oxygen Therapy) is a quite modern treatment in Thailand for nitrogen imbalance (decompression sickness syndrome or Caisson disease). How can we apply it to treat the autism? A hypothesis shows evidence that neurons surrounding the permanently damaged epicenter of injury can be reactivated with increased oxygen. Oxygen exists in the blood in two forms, combined with hemoglobin and dissolved in plasma. More oxygen is transported by hemoglobin, but oxygen is delivered to the tissues in dissolved form by the liquid portion of blood. HBOT can increase in plasma oxygen to the tissues including the brain. A little change in oxygen can make the better improvements in : cognitive ability, socialization, sleep, calmness, decreased stimming and language. It can make increased in Glutathione (GSH), and Glutathione (GSH) can decreased in oxidative stress with effected to remove metal compounds (mercury) to improve the autism.

This clinical trial study divided into 3 group populations 1. general autism 2. post-treatment chiropractic autism 3. medicated autism. This comparative study shows the major clinical symptoms before and after the treatment with HBOT. This study results and analysis are the most important for our further projects planning.


Condition Intervention Phase
Autistic Disorder
Procedure: oxygen (Hyperbaric Oxygen Therapy)
Phase I

MedlinePlus related topics:   Autism   

ChemIDplus related topics:   Carbon monoxide   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Non-Randomized, Open Label, Single Group Assignment, Safety/Efficacy Study
Official Title:   A Prospective, Non-Randomized, Open-Label Study on the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic Children

Further study details as provided by Vachira Phuket Hospital:

Primary Outcome Measures:
  • Developmental and Skill training assessment, Rajanukul Hospital 5th edition [ Time Frame: 10 sessions assessment ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Developmental and Skill training assessment, Rajanukul Hospital 5th edition [ Time Frame: 20 sessions assessment ] [ Designated as safety issue: Yes ]

Enrollment:   7
Study Start Date:   July 2007
Study Completion Date:   April 2008
Primary Completion Date:   April 2008 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
HBOT: Experimental
HBOT
Procedure: oxygen (Hyperbaric Oxygen Therapy)

Current Accepted Applications of HBOT (2008) Jan 2003, ANDI International

  1. Air or Gas Embolus
  2. Decompression Illness
  3. Carbon Monoxide poising
  4. Clostridial Myonecrosis (Gas Gangrene)
  5. Necrotizing Fasciitis
  6. Crush Injury (Compartment syndromes)
  7. Selected Problem Wounds
  8. Compromised Skin Flaps or Grafts
  9. Refractory Osteomyelitis
  10. Exceptional Anemia due to Blood loss
  11. Osteoradionecrosis
  12. Thermal Burns and Radiation Tissue Damage
  13. Diabetic Wounds
  14. Intra-Cranial Abscess
  15. Brain Injury and other Head Trauma
  16. Cerebral Palsy
  17. High Altitude Sickness
  18. Lyme disease

Show detailed description  Show Detailed Description

  Eligibility
Ages Eligible for Study:   5 Years to 9 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion criteria:

  1. Both sexes
  2. All aged-group
  3. All educated group
  4. Diagnosis - Autistic disorder, Autistic spectrums
  5. Major symptoms - delayed development, delayed speech

Exclusion criteria:

  1. Uncontrolled severe explosive behaviours
  2. Uncontrolled organic or physical symptoms such as seizure, ear infection
  3. Severe phobic or fearful symptoms
  4. No parent or caretaker
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00670891

Locations
Thailand
Vachira Phuket Hospital    
      Phuket, Thailand, 83000

Sponsors and Collaborators
Vachira Phuket Hospital

Investigators
Principal Investigator:     Jessada Chungpaibulpatana, MD.     Vachira Phuket Hospital    
  More Information


Responsible Party:   Vachira Phuket Hospital ( HBOT and Developmental Clinic Team )
Study ID Numbers:   VP 000001
First Received:   April 29, 2008
Last Updated:   May 26, 2008
ClinicalTrials.gov Identifier:   NCT00670891
Health Authority:   Thailand: Ministry of Public Health

Study placed in the following topic categories:
Child Development Disorders, Pervasive
Developmental Disabilities
Mental Disorders
Autistic Disorder
Mental Disorders Diagnosed in Childhood
Carbon Monoxide

ClinicalTrials.gov processed this record on October 07, 2008




Links to all studies - primarily for crawlers